{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:07:43Z","timestamp":1792814863393,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004147","name":"Tsinghua University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005196","name":"Chinese Academy of Agricultural Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573323"],"award-info":[{"award-number":["82573323"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.phrs.2026.108349","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:59:41Z","timestamp":1784645981000},"page":"108349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Celastrol\u2019s covalent strike on HK2: Breaking a metabolic\u2013epigenetic circuit to impede bladder cancer"],"prefix":"10.1016","volume":"231","author":[{"given":"Tong","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoying","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahe","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichao","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5601-9670","authenticated-orcid":false,"given":"Cheng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phrs.2026.108349_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.eururo.2025.09.4173","article-title":"The Future of Bladder Preservation for Muscle-invasive Bladder Cancer","volume":"89","author":"Fu","year":"2026","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108349_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.eururo.2025.03.017","article-title":"Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group","volume":"89","author":"Gupta","year":"2026","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108349_bib3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s13046-025-03591-5","article-title":"Lactate-driven lactylation of HNRNPA1 orchestrates PKM2 splicing and glycolytic reprogramming in bladder cancer","volume":"44","author":"Wang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.phrs.2026.108349_bib4","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s41417-025-00947-z","article-title":"Integrated spatial transcriptome and metabolism study reveals metabolic heterogeneity in human bladder cancer","volume":"32","author":"Lu","year":"2025","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.phrs.2026.108349_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","article-title":"Lactate and lactylation in cancer","volume":"10","author":"Chen","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"11","key":"10.1016\/j.phrs.2026.108349_bib6","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.7150\/ijbs.116088","article-title":"Lactate metabolic reprogramming and histone lactylation modification in sepsis","volume":"21","author":"Zhang","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phrs.2026.108349_bib7","article-title":"Interplay between metabolic reprogramming and post-translational modifications: from glycolysis to lactylation","volume":"14","author":"Wu","year":"2023","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.phrs.2026.108349_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13478","article-title":"Lactate-induced protein lactylation: A bridge between epigenetics and metabolic reprogramming in cancer","volume":"56","author":"Wang","year":"2023","journal-title":"Cell. Prolif."},{"issue":"11","key":"10.1016\/j.phrs.2026.108349_bib9","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.ccell.2024.09.006","article-title":"Lactylation in cancer: Current understanding and challenges","volume":"42","author":"Li","year":"2024","journal-title":"Cancer Cell."},{"issue":"2","key":"10.1016\/j.phrs.2026.108349_bib10","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.cell.2023.11.022","article-title":"Metabolic regulation of homologous recombination repair by MRE11 lactylation","volume":"187","author":"Chen","year":"2024","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.phrs.2026.108349_bib11","doi-asserted-by":"crossref","first-page":"8473","DOI":"10.7150\/thno.112009","article-title":"Chitosan activates NLRP3 inflammasome and cGAS-STING to suppress cancer progression through hexokinase 2 dissociation and mitochondrial dysfunction","volume":"15","author":"Li","year":"2025","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.phrs.2026.108349_bib12","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.7150\/thno.104310","article-title":"Glucose homeostasis controls N-acetyltransferase 10-mediated ac4C modification of HK2 to drive gastric tumorigenesis","volume":"15","author":"Wang","year":"2025","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.phrs.2026.108349_bib13","doi-asserted-by":"crossref","first-page":"790","DOI":"10.7150\/ijms.105553","article-title":"The Role of HK2 in Tumorigenesis and Development: Potential for Targeted Therapy with Natural Products","volume":"22","author":"He","year":"2025","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108349_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41392-022-01231-4","article-title":"Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1","volume":"8","author":"Xu","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"35","key":"10.1016\/j.phrs.2026.108349_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202404971","article-title":"Glutathione-Scavenging Celastrol-Cu Nanoparticles Induce Self-Amplified Cuproptosis for Augmented Cancer Immunotherapy","volume":"36","author":"Lu","year":"2024","journal-title":"Adv. Mater."},{"issue":"22","key":"10.1016\/j.phrs.2026.108349_bib16","doi-asserted-by":"crossref","first-page":"10290","DOI":"10.7150\/thno.46728","article-title":"Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.phrs.2026.108349_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106487","article-title":"Celastrol inhibits lung cancer growth by triggering histone acetylation and acting synergically with HDAC inhibitors","volume":"185","author":"Chen","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2026.108349_bib18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.canlet.2021.08.030","article-title":"Celastrol in cancer therapy: Recent developments, challenges and prospects","volume":"521","author":"Lim","year":"2021","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.phrs.2026.108349_bib19","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/cac2.12374","article-title":"Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities","volume":"42","author":"Ge","year":"2022","journal-title":"Cancer Commun (Lond)"},{"issue":"12","key":"10.1016\/j.phrs.2026.108349_bib20","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","article-title":"Metabolic reprogramming and epigenetic modifications on the path to cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Protein Cell."},{"issue":"1","key":"10.1016\/j.phrs.2026.108349_bib21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","article-title":"Lactate metabolism in human health and disease","volume":"7","author":"Li","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"7779","key":"10.1016\/j.phrs.2026.108349_bib22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2026.108349_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-019-0805-7","article-title":"The interplay between m6A RNA methylation and noncoding RNA in cancer","volume":"12","author":"Ma","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108349_bib24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","article-title":"The role of m6A modification in the biological functions and diseases","volume":"6","author":"Jiang","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2026.108349_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","article-title":"The role of m6A RNA methylation in cancer metabolism","volume":"21","author":"An","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2026.108349_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12943-022-01704-8","article-title":"m(6)A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion","volume":"22","author":"Cao","year":"2023","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.phrs.2026.108349_bib27","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41419-024-06931-z","article-title":"Role of N6-methyladenosine in tumor neovascularization","volume":"15","author":"Zhao","year":"2024","journal-title":"Cell. Death Dis."},{"issue":"9","key":"10.1016\/j.phrs.2026.108349_bib28","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","article-title":"Lactylation-driven METTL3-mediated RNA m(6)A modification promotes immunosuppression of tumor-infiltrating myeloid cells","volume":"82","author":"Xiong","year":"2022","journal-title":"Mol. Cell."},{"issue":"14","key":"10.1016\/j.phrs.2026.108349_bib29","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1016\/j.molcel.2025.06.017","article-title":"YTHDC1 lactylation regulates its phase separation to enhance target mRNA stability and promote RCC progression","volume":"85","author":"Dai","year":"2025","journal-title":"Mol. Cell."},{"issue":"1","key":"10.1016\/j.phrs.2026.108349_bib30","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1038\/s41467-023-42025-8","article-title":"Lactylation of METTL16 promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer","volume":"14","author":"Sun","year":"2023","journal-title":"Nat. Commun."},{"issue":"46","key":"10.1016\/j.phrs.2026.108349_bib31","article-title":"Lactylation-Driven IGF2BP3-Mediated Serine Metabolism Reprogramming and RNA m6A-Modification Promotes Lenvatinib Resistance in HCC","volume":"11","author":"Lu","year":"2024","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"33","key":"10.1016\/j.phrs.2026.108349_bib32","article-title":"WTAP Mediated m6A Modification Stabilizes PDIA3P1 and Promotes Tumor Progression Driven by Histone Lactylation in Esophageal Squamous Cell Carcinoma","volume":"12","author":"Huang","year":"2025","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.phrs.2026.108349_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103194","article-title":"Histone lactylation-regulated METTL3 promotes ferroptosis via m6A-modification on ACSL4 in sepsis-associated lung injury","volume":"74","author":"Wu","year":"2024","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108349_bib34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41419-024-06509-9","article-title":"The m(6)A reader IGF2BP2 regulates glycolytic metabolism and mediates histone lactylation to enhance hepatic stellate cell activation and liver fibrosis","volume":"15","author":"Zhou","year":"2024","journal-title":"Cell. Death Dis."},{"issue":"1","key":"10.1016\/j.phrs.2026.108349_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13059-021-02308-z","article-title":"Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma","volume":"22","author":"Yu","year":"2021","journal-title":"Genome Biol."},{"issue":"43","key":"10.1016\/j.phrs.2026.108349_bib36","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2409132121","article-title":"Lactylation of RNA m(6)A demethylase ALKBH5 promotes innate immune response to DNA herpesviruses and mpox virus","volume":"121","author":"Li","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.phrs.2026.108349_bib37","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s44321-024-00025-1","article-title":"Lactylation-driven FTO targets CDK2 to aggravate microvascular anomalies in diabetic retinopathy","volume":"16","author":"Chen","year":"2024","journal-title":"EMBO Mol. Med."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826002641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826002641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:06:15Z","timestamp":1789398375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826002641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":37,"alternative-id":["S1043661826002641"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108349","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Celastrol\u2019s covalent strike on HK2: Breaking a metabolic\u2013epigenetic circuit to impede bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108349","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108349"}}